Roger W. Satterthwaite, M.D., M.P.H.
Roger Satterthwaite, M.D., M.P.H., started his medical career as a 19-year-old medic in the U.S. Army. After stints as a paratrooper and in the mountain infantry, he completed his Bachelor of Arts degree in history at Dartmouth College with an emphasis in Latin American studies and lettered on the nationally ranked Dartmouth cross country team. Between 1987 and 1991, Dr. Satterthwaite then completed both a master's degree at the Mailman School of Public Health and his medical degree at the College of Physicians and Surgeons at top-ranked Columbia University in New York City. He followed with an equally rigorous urology residency at the University of Southern California/Norris Cancer Center, where he published in the transplantation literature.
From 1997 to 2003, Dr. Satterthwaite served in the U.S. Air Force as chief of urology at MacDill Air Force Base and Royal Air Force Base Lakenheath, in addition to directing the Surgical Subspecialty Flight at Travis Air Force Base. After being selected for lieutenant colonel, Dr. Satterthwaite departed the Air Force for two years of private practice in Hawaii. He then joined City of Hope in 2005, first as a fellow in urologic oncology and robotic surgery, followed by a staff appointment in the City of Hope Medical Group. Dr. Satterthwaite is a highly experienced robotic surgeon who has also performed thousands of endoscopic procedures for benign urologic disease such as stones and urinary retention. Dr. Satterthwaite also helped found and for a time directed the community urology practices for City of Hope.
Dr. Satterthwaite has lived in El Salvador, Costa Rica and England, travelled extensively through Asia, studied abroad in Austria and Honduras and worked on Air Force bases in Germany and Turkey, in support of Operation Northern Watch. He is a member of the Los Angeles County, California and American Medical Associations as well as the American Urology Association. He has served on the Board of the City of Hope Medical Group and served his specialty in the American Medical Association House of Delegates, as well as a lobbyist on Capitol Hill. Dr. Satterthwaite proudly supports Doctors Without Borders, Physicians for Human Rights and Amnesty International. He speaks fluent Spanish, high school German and French, basic Mandarin and, from 15 years of taekwondo, can count to 20 in Korean.
Dr. Satterthwaite sees patients in the COH-Pasadena clinic.
Pasadena
Suite 220
Pasadena, CA 91105
Medical Board of Hawaii, Physician, Active License
Medical Board of California, Physician and Surgeon, Active License
Medical Board of Pennsylvania, Physician and Surgeon, Inactive License
National Board of Medical Examiners, Part I-III
2001 and 2011, Certified by American Board of Urology
M.D., M.P.H. 1987 -1991, College of Physicians and Surgeons, Columbia University, New York, NY
Dartmouth College, Hanover, NH
Bachelor of Arts, History.
2005 -2006, Fellow, Urologic Oncology, Robotic and Laparoscopic Surgery, City of Hope, Duarte, CA
1991 -1997, Internship and Residency, Departments of Surgery and Urology, University of Southern California, Los Angeles, CA
1991 -1997, Internship and Residency, Departments of Surgery and Urology, University of Southern California, Los Angeles, CA
2006 - present, Surgeon, Division of Urology and Urologic Oncology, City of Hope, Pasadena and Arcadia, CA
2005, Kaiser Hawaii and Tripler Army Medical Center, Honolulu, HI
2003 - 2005, Private practice, Honolulu, HI
2002, US Air Force, Chief, Surgical Subspecialty Flight, Travis AFB, CA
2001 - 2003, US Air Force, Staff Urologist, Travis AFB, CA
1999 - 2001, US Air Force, Chief of Urology, RAF Lakenheath, United Kingdom
1997 - 1999, US Air Force, Chief of Urology, MacDill AFB, FL
1984 - 1987, US Army National Guard, Chief Medic, 3/172nd Mountain Infantry, Ethan Allen Firing Range, VT
1981 - 1984, US Army, Medic, MEDDAC, Ft. Benning, GA
1/508th, 82nd Airborne Division, Ft. Bragg, NC
- Satterthwaite R et al. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation. 1998 Feb 15; 65(3): 446-9; Satterthwaite R et al. Risks of transplanting kidneys from Hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation. 1997 Aug 15; 64(3): 432-5; Satterthwaite R et al. Outcome of en-bloc and single kidney transplants from very young cadaveric donors. Transplantation. 1997 May 27; 63(10): 1405-10